Unsupported Browser
The American College of Surgeons website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
ACS
Bulletin

Coming next month in JACS and online now: Clinical value of hernia mesh pathology evaluation

There is no clinical value in submitting mesh specimen for microscopic surgical pathology evaluation, according to a new study published in JACS.

ACS

April 1, 2019

Negin Fadaee, AA; Laura Mazer, MD; Rajeev Sharma, MD; Isabel Capati, RN, BSN; Bonnie Balzer, MD, PhD; and Shirin Towfigh, MD, FACS, report in the May 2019 issue of the Journal of the American College of Surgeons (JACS) that there is no clinical value in submitting mesh specimens for microscopic surgical pathology evaluation, regardless of clinical indication for mesh removal, and they determined that no clinical claims can be made based on pathology findings from explanted mesh. Meanwhile, microscopic evaluation does incur additional cost to the consumer. The authors recommend explanted mesh be submitted for gross examination only for documentation purposes in the medical records.

This article and all other JACS content is available at journalacs.org.